Moderna went public in late 2018, bursting on the scene as the biggest biotech IPO in history. Timothy Springer, a Harvard medical professor, saw his stake in the company fatten his bottom line by a whopping $320 million by the end of the trading day. After that, he REALLY got rich.

Read The FULL STORY at MarketWatch